David Hollander insider trades

Open-market stock purchases and sales by David Hollander, Director at Kiora Pharmaceuticals Inc, from SEC Form 4 filings since Nov 11, 2019.

Recent trades

DateStockTradeValue
Jun 10, 2026KPRX Kiora Pharmaceuticals IncBought (not open market)—

Companies traded

  • KPRX Kiora Pharmaceuticals Inc: other filings, last Jun 10, 2026
  • RVNC Revance Therapeutics, Inc: 1 sale, last Feb 6, 2025
  • AERI Aerie Pharmaceuticals Inc: other filings, last Feb 4, 2022

Get free alerts when David Hollander files a new trade →